Thoma Bravo Acquires Greenphire from The Riverside Company
May 26, 2021
Thoma Bravo has agreed to acquire Greenphire, a King of Prussia, Pennsylvania–based leader in financial lifecycle management software for clinical trials, from The Riverside Company in a strategic growth investment. The deal (expected to close in Q2 2021) will support Greenphire’s product innovation and global expansion; financial terms were not disclosed.
- Buyers
- Thoma Bravo
- Targets
- Greenphire
- Sellers
- The Riverside Company
- Industry
- Cloud & SaaS
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Thoma Bravo and 7RIDGE Invest in Trading Technologies
November 10, 2025
Cloud & SaaS
Thoma Bravo has closed an investment in Trading Technologies, joining existing investor 7RIDGE in the company's ownership to support the next phase of platform expansion and product innovation. Terms were not disclosed; advisors to the transaction included Houlihan Lokey and Barclays for Trading Technologies and Ardea Partners and Goodwin Procter for Thoma Bravo.
-
Thoma Bravo, Bain Capital & LLR Partners Complete Merger of Suvoda and Greenphire (Combined Company: Suvoda)
April 24, 2025
Healthcare Services
Suvoda and Greenphire, both clinical trial technology companies, have completed their previously announced merger, bringing the businesses under common ownership and management. The combined company (known as Suvoda) unifies Suvoda’s randomization/trial supply and eClinical capabilities with Greenphire’s clinical trial payments, budgeting, and patient support to deliver an end-to-end platform for trial stakeholders.
-
Greenphire Acquires Clincierge to Expand Clinical Trial Participant Support Services
February 1, 2024
Healthcare Services
Greenphire, a clinical trial software provider, announced its acquisition of Clincierge, a concierge travel and logistics support provider for patients participating in clinical trials. The combined offering is intended to deliver a more patient-centric, end-to-end participant experience for sponsors and CROs, while improving trial efficiency through integrated technology and services.
-
Thoma Bravo Completes Growth Investment in Hypergene
December 14, 2023
Cloud & SaaS
Thoma Bravo has completed a majority growth investment in Hypergene, a Malmö-based SaaS provider of corporate performance management and project & portfolio management software. The investment will support Hypergene's product development and European expansion; Monterro and other minority shareholders sold their stakes with Hypergene management remaining as shareholders.
-
Thoma Bravo Acquires NextGen Healthcare
November 10, 2023
Cloud & SaaS
Thoma Bravo, a leading software-focused private equity firm, has completed the acquisition of NextGen Healthcare, Inc. for $1.8 billion, taking the company private at $23.95 per share. The transaction (previously announced Sept. 6, 2023) will delist NextGen from Nasdaq and aims to accelerate product innovation and growth across NextGen's cloud-based ambulatory healthcare technology offerings.
-
Thoma Bravo Acquires Calabrio from KKR
April 19, 2021
Software
Thoma Bravo, a leading private equity firm focused on software, has completed the acquisition of Calabrio, a cloud-first customer experience intelligence and workforce engagement management software company, from KKR. The deal will provide Calabrio with new capital and Thoma Bravo's operational expertise to accelerate the company’s cloud-first growth, organic product investment and targeted inorganic expansion.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.